|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yen fs"
Showing items 21-70 of 90 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-06-12 |
Sodium-glucose cotransporter-2 inhibitors and nephritis among patients with systemic lupus erythematosus
|
Yen, FS;Wang, SI;Hsu, CC;Hwu, CM;Wei, JCC |
| 國家衛生研究院 |
2024-04-30 |
Sodium-glucose cotransporter-2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease
|
Yen, FS;Hwu, CM;Liu, JS;Wu, YL;Chong, K;Hsu, CC |
| 國家衛生研究院 |
2024-04 |
Metformin and the risks of cellulitis, foot infections, and amputation in patients with type 2 diabetes
|
Yeh, YK;Yen, FS;Wei, JC;Hu, KC;Yu, TS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2024-01-04 |
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
|
Yen, FS;Hou, MC;Wei, JCC;Shih, YH;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-12-20 |
Sodium-glucose cotransporter 2 inhibitors and risk of retinopathy in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Yu, TS;Hung, YT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-11-30 |
Parental income level and risk of developing type 2 diabetes in youth
|
Yen, FS;Wei, JCC;Liu, JS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-10-31 |
Reply
|
Yen, FS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-09-21 |
Reply to the Letter to the Editor: "Glucagon-like Peptide-1 Receptor Agonists: Best Choice for Patients with Cirrhosis and Diabetes?"
|
Yen, FS;Yu, TS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-06-16 |
Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes
|
Yen, FS;Hou, MC;Cheng-Chung Wei, J;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-05-09 |
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Shih, YH;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-02-17 |
Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Hung, YT;Hsu, CY;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-01-04 |
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
|
Yen, FS;Hou, MC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-01 |
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Yip, HT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-01 |
The risk of severe hypoglycemia and mortality in patients with type 2 diabetes and discharged with acute liver injury
|
Yen, FS;Hou, MC;Pan, CW;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-12-21 |
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
|
Yen, FS;Hou, MC;Wei, JCC;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-11-15 |
Sulfonylurea use in patients with type 2 diabetes and COPD: A nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Yu, TS;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-11 |
Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes
|
Yen, FS;Wei, JCC;Hung, YT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-10-19 |
Metformin use before influenza vaccination may lower the risks of influenza and related complications
|
Yen, FS;Wei, JC;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-09-03 |
Metformin and the risk of chronic urticaria in patients with type 2 diabetes
|
Yen, FS;Hsu, CC;Hu, KC;Hung, YT;Hsu, CY;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2022-08-22 |
Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS;Wei, JCC;Chiu, LT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-07-18 |
Diabetes, hypertension, and the risk of dementia
|
Yen, FS;Wei, JC;Yip, HT;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2022-07-05 |
Metformin and the development of asthma in patients with type 2 diabetes
|
Yen, FS;Hsu, CC;Shih, YH;Pan, WL;Wei, JCC;Hwu, CM |
| 國家衛生研究院 |
2022-06-21 |
Clinical course of adolescents with type 2 diabetes mellitus: A nationwide cohort study in Taiwan
|
Yen, FS;Wei, JC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-04-28 |
Role of metformin in morbidity and mortality associated with urinary tract infections in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Shih, YS;Pan, WL;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-02-28 |
Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Shih, YS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-02-16 |
Selection and warning of evidence-based antidiabetic medications for patients with chronic liver disease
|
Yen, FS;Hsu, CC;Wei, JCC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2022-01 |
Diabetes, hypertension, and cardiovascular disease development
|
Yen, FS;Wei, JCC;Chiu, LT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-12-09 |
Thiazolidinedione use in individuals with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS;Wei, JCC;Yang, YC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-12 |
Early-onset type 2 diabetes <60 years and risk of vascular complications
|
Yen, FS;Lo, YR;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2021-11-18 |
The risk of nephropathy, retinopathy, and leg amputation in patients with diabetes and hypertension: A nationwide, population-based retrospective cohort study
|
Yen, FS;Wei, JCC;Shih, YH;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-09-16 |
Epidemiological characteristics of diabetic kidney disease in Taiwan
|
Wang, JS;Yen, FS;Lin, KD;Shin, SJ;Hsu, YH;Hsu, CC |
| 國家衛生研究院 |
2021-07-01 |
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
|
Yen, FS;Huang, YH;Hou, MC;Hwu, CM;Lo, YR;Shin, SJ;Hsu, CC |
| 國家衛生研究院 |
2021-07 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS;Wei, CC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-06-12 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS;Lai, JN;Wei, JCC;Chiu, LT;Hsu, CC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2021-04-29 |
Urate-lowering therapy and chronic kidney disease development in patients with gout
|
Yen, FS;Wei, JCC;Chang, CL;Yang, CC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-03-05 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
|
Yen, FS;Hsu, CC;Su, YC;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2021-02-18 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS;Wei, JC;Lin, MC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-01-10 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan
|
Yen, FS;Wei, JCC;Yip, HT;Hwu, CM;Hou, MC;Hsu, CC |
| 中山醫學大學 |
2021 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS; Wei, JCC; Lin, MC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
|
Yen, FS; Wei, JCC; Yang, YC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy A nationwide retrospective cohort study
|
Yen, FS; Hsu, CC; Su, YC; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2021 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan
|
Yen, FS; Wei, JCC; Yip, HT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2021 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hsu, CC; Hou, MC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
|
Yen, FS; Wei, JCC; Chang, CL; Yang, CC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering therapy exerts protective effects against hypertension development in patients with gout
|
Lin, KH; Yen, FS; Li, HL; Wei, JCC; Hsu, CC; Yang, CC; Hwu, CM |
| 國家衛生研究院 |
2020-12-14 |
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
|
Yen, FS;Lai, JN;Wei, JC;Chiu, LT;Hwu, CM;Hou, MC;Hsu, CC |
| 國家衛生研究院 |
2020-10-30 |
Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and liver cirrhosis
|
Yen, FS;Wei, JC;Chiu, LT;Hsu, CC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2020-09 |
The factors associated with insulin nonpersistence in persons with type 2 diabetes
|
Yen, FS;Wei, JCC;Liu, JS;Hsu, CC;Hwu, CM |
Showing items 21-70 of 90 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
